In contrast, KIM1 has stronger association with kidney function and is highly expressed only after renal injury (Kondratowicz et al., 2011; Yuan et al., 2015; Costafreda and Kaplan, 2018), which makes it a more specific and maybe also safer therapeutic target for COVID-19 patients with kidney diseases. This evidence concerns the gene HAVCR1 and kidney disorder.